These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21525855)

  • 21. Interleukin-17A promotes early but attenuates established disease in crescentic glomerulonephritis in mice.
    Odobasic D; Gan PY; Summers SA; Semple TJ; Muljadi RC; Iwakura Y; Kitching AR; Holdsworth SR
    Am J Pathol; 2011 Sep; 179(3):1188-98. PubMed ID: 21741931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis.
    Kitching AR; Tipping PG; Timoshanko JR; Holdsworth SR
    Kidney Int; 2000 Feb; 57(2):518-25. PubMed ID: 10652028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-10 Receptor Signaling Empowers Regulatory T Cells to Control Th17 Responses and Protect from GN.
    Diefenhardt P; Nosko A; Kluger MA; Richter JV; Wegscheid C; Kobayashi Y; Tiegs G; Huber S; Flavell RA; Stahl RAK; Steinmetz OM
    J Am Soc Nephrol; 2018 Jul; 29(7):1825-1837. PubMed ID: 29866800
    [No Abstract]   [Full Text] [Related]  

  • 24. Limitations of Foxp3(+) Treg depletion following viral infection in DEREG mice.
    Christiaansen AF; Boggiatto PM; Varga SM
    J Immunol Methods; 2014 Apr; 406():58-65. PubMed ID: 24642426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the renal CD4+ T-cell response in experimental autoimmune glomerulonephritis.
    Hopfer H; Holzer J; Hünemörder S; Paust HJ; Sachs M; Meyer-Schwesinger C; Turner JE; Panzer U; Mittrücker HW
    Kidney Int; 2012 Jul; 82(1):60-71. PubMed ID: 22437418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innate and adaptive immunity in experimental glomerulonephritis: a pathfinder tale.
    Artinger K; Kirsch AH; Aringer I; Moschovaki-Filippidou F; Eller P; Rosenkranz AR; Eller K
    Pediatr Nephrol; 2017 Jun; 32(6):943-947. PubMed ID: 27169420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous foxp3(+) T-regulatory cells suppress anti-glomerular basement membrane nephritis.
    Ooi JD; Snelgrove SL; Engel DR; Hochheiser K; Ludwig-Portugall I; Nozaki Y; O'Sullivan KM; Hickey MJ; Holdsworth SR; Kurts C; Kitching AR
    Kidney Int; 2011 May; 79(9):977-86. PubMed ID: 21248715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherosclerosis-Driven Treg Plasticity Results in Formation of a Dysfunctional Subset of Plastic IFNγ+ Th1/Tregs.
    Butcher MJ; Filipowicz AR; Waseem TC; McGary CM; Crow KJ; Magilnick N; Boldin M; Lundberg PS; Galkina EV
    Circ Res; 2016 Nov; 119(11):1190-1203. PubMed ID: 27635087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FMS-like tyrosine kinase 3 ligand treatment does not ameliorate experimental rapidly progressive glomerulonephritis.
    Ghali JR; O'Sullivan KM; Eggenhuizen PJ; Holdsworth SR; Kitching AR
    PLoS One; 2015; 10(4):e0123118. PubMed ID: 25849330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-12 directs severe renal injury, crescent formation and Th1 responses in murine glomerulonephritis.
    Kitching AR; Tipping PG; Holdsworth SR
    Eur J Immunol; 1999 Jan; 29(1):1-10. PubMed ID: 9933080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis.
    Odobasic D; Kitching AR; Semple TJ; Holdsworth SR
    J Am Soc Nephrol; 2007 Mar; 18(3):760-70. PubMed ID: 17267745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depletion of Foxp3+ regulatory T cells increases severity of mechanical allodynia and significantly alters systemic cytokine levels following peripheral nerve injury.
    Lees JG; Duffy SS; Perera CJ; Moalem-Taylor G
    Cytokine; 2015 Feb; 71(2):207-14. PubMed ID: 25461400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCR5 deficiency aggravates crescentic glomerulonephritis in mice.
    Turner JE; Paust HJ; Steinmetz OM; Peters A; Meyer-Schwesinger C; Heymann F; Helmchen U; Fehr S; Horuk R; Wenzel U; Kurts C; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2008 Nov; 181(9):6546-56. PubMed ID: 18941245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treg depletion attenuates irradiation-induced pulmonary fibrosis by reducing fibrocyte accumulation, inducing Th17 response, and shifting IFN-γ, IL-12/IL-4, IL-5 balance.
    Xiong S; Guo R; Yang Z; Xu L; Du L; Li R; Xiao F; Wang Q; Zhu M; Pan X
    Immunobiology; 2015 Nov; 220(11):1284-91. PubMed ID: 26224246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous IL-22 is dispensable for experimental glomerulonephritis.
    Gnirck AC; Wunderlich M; Becker M; Xiong T; Weinert E; Meyer-Schwesinger C; Dumoutier L; Renauld JC; Huber S; Panzer U; Turner JE
    Am J Physiol Renal Physiol; 2019 Apr; 316(4):F712-F722. PubMed ID: 30724106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous IL-13 limits humoral responses and injury in experimental glomerulonephritis but does not regulate Th1 cell-mediated crescentic glomerulonephritis.
    Kitching AR; Turner AL; Wilson GR; Edgtton KL; Tipping PG; Holdsworth SR
    J Am Soc Nephrol; 2004 Sep; 15(9):2373-82. PubMed ID: 15339986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis.
    Feng T; Cao AT; Weaver CT; Elson CO; Cong Y
    Gastroenterology; 2011 Jun; 140(7):2031-43. PubMed ID: 21419767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.
    Klages K; Mayer CT; Lahl K; Loddenkemper C; Teng MW; Ngiow SF; Smyth MJ; Hamann A; Huehn J; Sparwasser T
    Cancer Res; 2010 Oct; 70(20):7788-99. PubMed ID: 20924102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induced regulatory T cells are phenotypically unstable and do not protect mice from rapidly progressive glomerulonephritis.
    Ghali JR; Alikhan MA; Holdsworth SR; Kitching AR
    Immunology; 2017 Jan; 150(1):100-114. PubMed ID: 27606831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stat3 programs Th17-specific regulatory T cells to control GN.
    Kluger MA; Luig M; Wegscheid C; Goerke B; Paust HJ; Brix SR; Yan I; Mittrücker HW; Hagl B; Renner ED; Tiegs G; Wiech T; Stahl RA; Panzer U; Steinmetz OM
    J Am Soc Nephrol; 2014 Jun; 25(6):1291-302. PubMed ID: 24511136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.